0001127602-13-014615.txt : 20130426 0001127602-13-014615.hdr.sgml : 20130426 20130426173300 ACCESSION NUMBER: 0001127602-13-014615 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20130424 FILED AS OF DATE: 20130426 DATE AS OF CHANGE: 20130426 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: MCNAMEE BRIAN M CENTRAL INDEX KEY: 0001183885 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-12477 FILM NUMBER: 13788512 MAIL ADDRESS: STREET 1: AMGEN INC. STREET 2: ONE AMGEN CENTER DRIVE CITY: THOUSAND OAKS STATE: CA ZIP: 91320-1799 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: AMGEN INC CENTRAL INDEX KEY: 0000318154 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 953540776 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: ONE AMGEN CENTER DRIVE CITY: THOUSAND OAKS STATE: CA ZIP: 91320 BUSINESS PHONE: (805)447-1000 MAIL ADDRESS: STREET 1: ONE AMGEN CENTER DRIVE CITY: THOUSAND OAKS STATE: CA ZIP: 91320 FORMER COMPANY: FORMER CONFORMED NAME: AMGEN DATE OF NAME CHANGE: 19870305 4 1 form4.xml PRIMARY DOCUMENT X0306 4 2013-04-24 0000318154 AMGEN INC AMGN 0001183885 MCNAMEE BRIAN M ONE AMGEN CENTER DRIVE THOUSAND OAKS CA 91320-1799 1 SVP, Human Resources Common Stock 2013-04-24 4 S 0 6924 105.9453 D 58311 D Common Stock 2013-04-24 5 G 0 E 1000 0 D 57311 D Common Stock 2013-04-25 4 M 0 8662 54.69 A 65973 D Common Stock 2013-04-25 4 S 0 8662 107.9461 D 57311 D Common Stock 2013-04-25 4 F 0 1234 104.93 D 56077 D Nqso (Right to Buy) 54.69 2013-04-25 4 M 0 8662 0 D 2013-04-25 2021-04-25 Common Stock 8662 17588 D The price reported is an average price. The prices ranged from $105.90 to $106.00 per share. Full information regarding the number of shares sold at each separate price within the range set forth above is available upon request by the SEC, the issuer or a security holder of the issuer. The price reported is an average price. The prices ranged from $107.88 to $108.105 per share. Full information regarding the number of shares sold at each separate price within the range set forth above is available upon request by the SEC, the issuer or a security holder of the issuer. These shares include the following Restricted Stock Units (RSUs) granted under the Company's equity plans: 1,425 RSUs which fully vest on 4/28/2013; 2,900 RSUs which vest in two equal annual installments of 1,450 each commencing 4/26/2013; 22,081 RSUs which fully vest on 12/31/2014; 5,025 RSUs which vest in one installment of 2,475 on 4/25/2014 and one installment of 2,550 on 4/25/2015; 4,466 RSUs which vest in three installments of 1,473, 1,474 and 1,519 on 4/27/2014, 4/27/2015 and 4/27/2016, respectively; and 4,439 RSUs which vest in three installments of 1,464, 1,465 and 1,510 on 1/28/2015, 1/28/2016 and 1/28/2017, respectively. Vested RSUs will be paid in shares of the Company's common stock on a one-to-one basis. These shares include 106 Dividend Equivalents (DEs) granted pursuant to the Amgen Inc. 2009 Equity Incentive Plan and subject to a qualifying dividend reinvestment plan. DEs are credited on the reporting person's unvested RSUs and are paid out in shares of the Company's common stock on a one-to-one basis according to the vesting schedule, along with a cash payment for any remaining fractional share amount. /s/ Brian M. McNamee 2013-04-26